Science VC
Science VC
✓

Balancing Risk Across Two Industries | From Scientist to VC to Founder | Building Trust Among Co-founders | Protecting IP & Unlocking Markets | Fundraising Insights from Brazil with Larissa de Farias Viana, CEO @ APEXzymes | Ep 5

00:57:22
Podcasts
RSS
Link

ABOUT THIS EPISODE

Can a single innovation unlock multiple billion-dollar markets?

Larissa is the CEO of APEXzymes, a Brazilian biotech startup that produces cost-effective enzymes for sustainable industrial applications. During our conversation, Larissa shares her journey from chemical engineering to venture capital and entrepreneurship.

Topics in this episode

0:00 Intro
1:06 From Chemical Engineer to VC to Founder
4:56 Why Leave Venture Capital to Build a Startup?
6:38 How Self-Doubt Can Drive Innovation
8:25 Advice Before Starting APEXzymes
9:34 What Are Enzymes and Why Do They Matter?
12:19 APEXzymes’ Value Proposition
13:40 What Investors Miss About APEXzymes
17:13 Key Markets: Biofuels, Cattle Feed & More
19:48 How Enzymes Boost Productivity and Cut Methane
22:11 Early Commercial Traction
23:58 Communicating Traction to Investors
27:50 Turning Enzyme Strains Into Patentable Assets
32:43 Balancing Focus vs. Market Size
38:12 Lessons from Fundraising and Non-Dilutive Grants
43:33 What GRIDX Saw in APEXzymes
46:05 Building Trust With Co-Founders
49:00 Aligning Weekly Tasks With Long-Term Vision
55:22 What’s Next for APEXzymes?

Follow APEXzymes on LinkedIn https://www.linkedin.com/company/apexzymes/posts/?feedView=all
Connect with Larissa on LinkedIn https://www.linkedin.com/in/larissadefv/
Email Larissa larissa.viana@apexzymes.com

Connect with JP Orlov on LinkedIn https://www.linkedin.com/in/jp-orlov/
Follow Science VC on LinkedIn https://www.linkedin.com/company/science-vc
Follow Science VC on Instagram https://www.instagram.com/science.vc

Subscribe to Science VC on YouTube https://www.youtube.com/@ScienceVC
Subscribe to our Newsletter https://substack.com/@jporlov

Learn how WeArePalta can help your deeptech company communicate its science and impact https://www.wearepalta.com/

Technology
Entrepreneurship
Business
English
United States
Use API to fetch this episode in JSON

IN THIS EPISODE

Edit these tags

TRANSCRIPT 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

SEARCH PAST EPISODES

Search past episodes of Science VC.
Embed this search bar to your website

OTHER EPISODES IN THIS PODCAST

Picking the VCs You Approach | Protecting Your IP and Building Your Business Model | Creating Therapeutics for Animals Using Black Soldier Flies | Standing Out to Investors While Raising a Seed Round, with Gerardo Bluske, CBO @ ByBug | Ep 1

Picking the VCs You Approach | Protecting Your IP and Building Your Business Model | Creating Therapeutics for Animals Using Black Soldier Flies | Standing Out to Investors While Raising a Seed Round, with Gerardo Bluske, CBO @ ByBug | Ep 1

Why do founders have to be very picky about what VCs they approach?Gerardo Bluske is the Chief Business Officer of ByBug, a biotech startup that creates therapeutics for animals using black soldier flies. In this episode, Gerardo shares his insights about business development and fundraising.Topics…
00:56:05
SHARE
SAVE
The Business Case for Carbon Capture | A $200B Opportunity | Rethinking Industrial Supply Chains | Why You Need to Talk to Customers Early | Leveraging Non-Dilutive Capital with Alexander Ip, CEO @ CERT Systems | Ep 4

The Business Case for Carbon Capture | A $200B Opportunity | Rethinking Industrial Supply Chains | Why You Need to Talk to Customers Early | Leveraging Non-Dilutive Capital with Alexander Ip, CEO @ CERT Systems | Ep 4

Is it possible to transform carbon emissions into everyday products?Alex is the CEO of CERT Systems, a Canadian climatetech startup that converts CO2 emissions into high-value chemicals. In this episode, Alex shares his journey from the lab bench to raising non-dilutive capital. Topics in this epis…
00:58:04
SHARE
SAVE
Raising Capital in a Controversial Industry | Psychedelics & Mental Health | Building Investor Relationships | Showing Traction Before Regulatory Approval | Imposter Syndrome in LATAM Startups with Victoria Costa Paz, CEO @ EYWA | Ep 3

Raising Capital in a Controversial Industry | Psychedelics & Mental Health | Building Investor Relationships | Showing Traction Before Regulatory Approval | Imposter Syndrome in LATAM Startups with Victoria Costa Paz, CEO @ EYWA | Ep 3

There is a lot of stigma around psychedelics.Vicky is the CEO of EYWA, a biotech startup that produces molecules for mental health treatments. In this episode, we discussed the fundraising process for a startup working with psychedelics and the stigma surrounding the industry.Topics in this episode…
00:55:55
SHARE
SAVE
Disrupting Drug Discovery: Combining Quantum Electrochemistry and AI | Partnering with Oxford University | Why Second-Time Founders Have a Unique Edge | The Importance of Boldness and Patience with Diego Stone, CEO @ Qnity | Ep 2

Disrupting Drug Discovery: Combining Quantum Electrochemistry and AI | Partnering with Oxford University | Why Second-Time Founders Have a Unique Edge | The Importance of Boldness and Patience with Diego Stone, CEO @ Qnity | Ep 2

Investors don’t care how fancy your tech is.Diego is the CEO of Qnity, a pharmatech startup that uses quantum electrochemistry to develop devices for drug discovery and screening. In this episode, we discuss his lessons as a second-time founder and his insights on fundraising in the deeptech space.…
00:59:23
SHARE
SAVE
Disclaimer: The podcast and artwork embedded on this page are from JP Orlov, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
PROMOTED
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
PodcastAPI.com

RECOMMENDATIONS
Use API to fetch this episode